RGLBX | RWICX | RGLBX / RWICX | |
Total Expense Ratio | 1.52 | 1.06 | 143% |
Annual Report Gross Expense Ratio | 1.52 | 1.06 | 143% |
Fund Existence | 6 years | 23 years | - |
Gain YTD | 10.056 | 8.899 | 113% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16.7B | 131B | 13% |
Annual Yield % from dividends | 0.22 | 1.26 | 18% |
Returns for 1 year | 11.72 | 6.00 | 195% |
Returns for 3 years | 35.38 | 28.12 | 126% |
Returns for 5 years | 55.29 | 44.37 | 125% |
Returns for 10 years | N/A | 51.42 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IHE | 66.29 | 0.79 | +1.21% |
iShares US Pharmaceuticals ETF | |||
GCAD | 40.56 | 0.42 | +1.04% |
Gabelli Commercial Aerospace & Dfns ETF | |||
GSY | 50.14 | N/A | N/A |
Invesco Ultra Short Duration ETF | |||
MAV | 8.29 | -0.02 | -0.24% |
Pioneer Municipal High Income Advantage Fund | |||
FXB | 130.07 | -0.37 | -0.28% |
Invesco CcyShrs® British Pound Stlg |